e.l.f. Beauty, Inc.: Form 10-Q for the period ended Dec 31, 2022
Filed with the SEC on Feb 2, 2023 and accepted by EDGAR at Feb 2, 2023, 21:06 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2022-10-01 to 2022-12-31 | $146.5m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2022-04-01 to 2022-12-31 | $391.5m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2022-10-01 to 2022-12-31 | $47.8m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2022-04-01 to 2022-12-31 | $130.2m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2022-10-01 to 2022-12-31 | $98.7m | us-gaap:GrossProfit |
| Gross profit | 9 months2022-04-01 to 2022-12-31 | $261.3m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2022-10-01 to 2022-12-31 | $75.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2022-04-01 to 2022-12-31 | $201.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2022-10-01 to 2022-12-31 | $23.3m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2022-04-01 to 2022-12-31 | $60.1m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2022-10-01 to 2022-12-31 | $4.3m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2022-04-01 to 2022-12-31 | $10.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2022-10-01 to 2022-12-31 | $19.1m | us-gaap:NetIncomeLoss |
| Net income | 9 months2022-04-01 to 2022-12-31 | $45.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2022-10-01 to 2022-12-31 | $0.34 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2022-04-01 to 2022-12-31 | $0.82 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2022-10-01 to 2022-12-31 | $0.36 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2022-04-01 to 2022-12-31 | $0.87 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2022-10-01 to 2022-12-31 | 55,840,137 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2022-04-01 to 2022-12-31 | 54,906,065 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2022-04-01 to 2022-12-31 | $69.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2022-04-01 to 2022-12-31 | $1.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2022-12-31 | $87.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-12-31 | $262.9m | us-gaap:AssetsCurrent |
| Total assets | At period end2022-12-31 | $555.9m | us-gaap:Assets |
| Current liabilities | At period end2022-12-31 | $87.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-12-31 | $170.6m | us-gaap:Liabilities |
| Shareholders' equity | At period end2022-12-31 | $385.3m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001600033-23-000009. Last ingested by Listed: Oct 24, 2026, 15:14 ET. Listed shows no prices and gives no investment advice.